Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
National Center For Global Health And Medicine currently manages 3 pending office actions within the Transportation, E-Commerce & Mechanical Systems technology area. These 3 actions are handled by 3 distinct examiners, meaning each application is being reviewed by a different individual. This distribution suggests that the organization is engaging with multiple perspectives within the patent office's mechanical systems division.
The workload is divided between 2 distinct art units, providing a degree of technical focus while still involving different administrative groups. PATEL, SHERYL GOPAL is identified as the busiest examiner, though they are responsible for only 1 busiest examiner pending office action. Because the 3 pending office actions are spread across the examiners, no examiner has a larger share of the workload. This structure requires the organization to navigate the specific requirements of the examiners and 2 distinct art units simultaneously.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (67%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PATEL, SHERYL GOPAL | 1 | 10.7% | +14.4% |
| CELANI, NICHOLAS P | 1 | 45.8% | +42.3% |
| PIPIC, ALMA | 1 | 54.6% | +54.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19092478 | MEDICAL RECORD SUPPORT APPARATUS, MEDICAL RECORD SUPPORT SYSTEM, AND MEDICAL RECORD SUPPORT METHOD | PATEL, SHERYL GOPAL | 6d |
| 19086290 | AUTHENTICATION SUPPORT APPARATUS, AUTHENTICATION SUPPORT SYSTEM, AND AUTHENTICATION SUPPORT METHOD | CELANI, NICHOLAS P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19092478 | MEDICAL RECORD SUPPORT APPARATUS, MEDICAL RECORD SUPPORT SYSTEM, AND MEDICAL RECORD SUPPORT METHOD | PATEL, SHERYL GOPAL | 6d |
| 19086290 | AUTHENTICATION SUPPORT APPARATUS, AUTHENTICATION SUPPORT SYSTEM, AND AUTHENTICATION SUPPORT METHOD | CELANI, NICHOLAS P | — |
| 18268427 | TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID | PIPIC, ALMA | — |
| Art Unit | Apps |
|---|---|
| 3685 | 1 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19092478 | MEDICAL RECORD SUPPORT APPARATUS, MEDICAL RECORD SUPPORT SYSTEM, AND MEDICAL RECORD SUPPORT METHOD | PATEL, SHERYL GOPAL | 3685 | §101§103 | Final Rejection | 6d | Pending | Mar 27, 2025 |
| 19086290 | AUTHENTICATION SUPPORT APPARATUS, AUTHENTICATION SUPPORT SYSTEM, AND AUTHENTICATION SUPPORT METHOD | CELANI, NICHOLAS P | — | §101§103§112 | Non-Final OA | — | Pending | Mar 21, 2025 |
| 18268427 | TRANSPLANTATION DEVICE USING CHEMICALLY CROSSLINKED ALGINIC ACID | PIPIC, ALMA | 1617 | §103DP | Non-Final OA | — | Pending | Jun 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial